School of Medicine
Showing 1-13 of 13 Results
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests Methamphetamine Abuse
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences) and, by courtesy, of Medicine (Primary Care and Population Health) at the Stanford University Medical Center
Current Research and Scholarly Interests We use innovations from implementation science to improve public access to effective treatments for all health problems and especially behavioral health problems, including addiction and mental health disorders. Our credo is NO HEALTH WITHOUT BEHAVIORAL HEALTH. Our goal is to enhance a person's chances for the best outcomes possible, including a lifetime of recovery. We embrace our leadership role to advance the science of implementation and mentor the next generation of researchers.
M Windy McNerney, PhD
Clinical Assistant Professor (Affiliated) [Vapahcs], Psych/General Psychiatry and Psychology (Adult)
Bio Dr. M. Windy McNerney is Research Health Specialist in the MIRECC the VA Palo Alto, and a Clinical Assistant Professor (Affiliated) at Psychiatry and Behavioral Sciences at Stanford School of Medicine. She earned her PhD from the University of Notre Dame, went on to a postdoctoral position and Lawrence Livermore National Laboratory (DOE), and then completed fellowship at the WRIISC program at the VA and Stanford University.
Dr. McNerney is primarily interested in the neurophysiology and biochemistry of brain and mental health diseases, especially degenerative diseases, depression, TBI, PTSD, and addiction. She is collaborating with researchers to integrate brain imaging and biochemical markers in hopes to better understand these diseases. She also is taking a lead role in investigating the biochemistry of magnetic brain stimulation. She is currently teaching two classes at Stanford, entitled ?Addictions in Our World: From Physiology to Human Behavior,? and "The Opioid Epidemic: Using Neuroscience to Inform Policy and Law", which discuss the societal implications of addiction from a neurophysiological prospective.
McNerney, M. W., Hobday, T., Cole, B., Ganong R., Winas, N., Matthews, D., Hood, J., & Lane, S. (2019). Objective classification of mTBI using machine learning on a combination of frontal electroencephalography measurements and self-reported symptoms. Sports Medicine Open, 4, 14.
Heath, A., Taylor, J.L., & McNerney, M. W. (2018). rTMS for Alzheimer's diseases: where should we be stimulating? Expert Rev Neurother, 18, 903.
McNerney, M. W., Sheng, T., Nechvatal, J. M., Lee, A. G., Lyons, D. M., ... Adamson, M. M. (2018). Integration of neural and epigenetic contributions to posttraumatic stress symptoms: The role of hippocampal volume and glucocorticoid receptor gene methylation. PLOSONE, e0192222.
Mi, Z., Biswas, K., Fairchild, K., Davis-Karim, A., Phibbs, C., Forman, S., Thase, M., Georgette, G., Beale, R., Pittman, D., McNerney, M. W., Rosen, A., Huang, G., George, M., Noda, A., & Yesavage, J. (2017). Repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depression (TRMD) patients: Rational and design of a trail focusing on Veterans. Trails, 18, 409.
Bennion, B. J., Be, N. A., McNerney, M. W., Lao V., Carlson E., Valdez, C. A., et al. (2017). Predicting a drug?s membrane permeability: A computational model validated with in vitro permeability assay data. Journal of Physical Chemistry, B, 121, 5228-5237.
Ghasemi, M., Phillips C., Fahimi, A., McNerney M. W., & Salehi, A. (2017). Mechanisms of action and clinical efficacy of NMDA receptor modulators in mood disorders. Neuroscience & Biobehavioral Reviews, 13, 555-572.
See more publications at: https://www.ncbi.nlm.nih.gov/pubmed/?term=McNerney%20MW%5BAuthor%5D&cauthor=true&cauthor_uid=17107728
Life Science Research Professional, Psych/Public Mental Health & Population Sciences
Current Role at Stanford Assistant Clinical Research Coordinator
Martin Stefan Mumenthaler
Adjunct Professor, Psych/Public Mental Health & Population Sciences
Bio Martin Mumenthaler has a PharmD and a PhD in psychopharmacology from the University of Bern, Switzerland. He holds an appointment as Adjunct Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine where he has been conducting research programs in addiction medicine and psychopharmacology, and teaching and mentoring medical students and residents on a voluntary basis.
Dr. Mumenthaler has also been working in various full-time positions in the pharmaceutical industry as Director in Clinical Development as well as in Medical Affairs, and as a consultant for early-stage pharma- and biotech companies providing advice on designing and conducting clinical trials, and analyzing and interpreting study results, mainly in the field of addiction medicine and pain.
His academic research has focused on the effects of psychoactive drugs on human performance, Aerospace Medicine, Alzheimer?s disease, and addiction medicine, and in these areas he has presented his results internationally and published over twenty-five peer-reviewed scientific articles. He has also served as a reviewer for various scientific journals, and is a member of the Research Society on Alcoholism, and an Associate Fellow of the Aerospace Medical Association.